Brief Behavioral Treatment for Insomnia: A Meta-Analysis

Overview

Journal Behav Sleep Med

Publisher Routledge

Date 2021 Oct 11

PMID 34632908

Citations 8

Authors

Misol Kwon

Jia Wang

Gregory Wilding

Suzanne S Dickerson

Grace E Dean

Affiliations

Soon will be listed here.

Abstract

Purpose: The current study aims to quantify the effect of brief behavioral treatment for insomnia (BBTI) studies through meta-analysis.

Method: Searches were performed from inception to February 2020, reporting on the effects of BBTI using randomized controlled trials (RCT) (adults aged 32 to 84). The main outcome measures were sleep onset latency (SOL), wake after sleep onset (WASO), sleep efficiency (SE%), and total sleep time (TST).

Results: BBTI showed improved SOL compared with control group in mean difference at early (-15.42 [95% CI: -33.05 to -12.01; I2 =49%]) and late follow-up (-10.52 [95% CI: -1.12 to 0.54; I2=93%]). This was statistically significant at early follow-up, but not at late follow-up. The improvement of WASO by BBTI over the control group was shown at early follow-up (-17.47 [95% CI: -2.67 to 0.45; I2=90%]), and was statistically significant. For WASO, a non-statistically significant improvement of BBTI over the control group was shown at late follow-up (-12.77 [95% CI: -22.47 to -3.08; I2=0%]). SE% was shown improved statistically significant by BBTI over control group at early (4.47 [95% CI: -0.35 to 9.29; I2=98%]) and at late follow-up (6.52 [95% CI: -4.00 to 17.05; I2=89%]). The TST was shown no improvement by BBTI at early follow-up in mean difference (-2.97 [95% CI -38.83 to 32.90; I2=96%]). At late follow-up, TST was shown improvement in BBTI with mean difference (14.52 [95% CI: -31.64 to 60.68; I2=94%]) compared with the control group.

Conclusion: Current evidence suggests that BBTI can be considered preliminarily efficacious and can be used for samples of middle-aged and older adults.

Citing Articles

Kwon M, Zhu J, Wilding G, Larkin K, Gehrman P, Dickerson S Ann Behav Med. 2025; 59(1).

PMID: 39887070 PMC: 11783284. DOI: 10.1093/abm/kaae096.

Beyond continuous positive airway pressure for cardiovascular risk reduction in patients with obstructive sleep apnea.

Healy W, Kundel V, Taub P, Cho Y, Healy S, Kwon Y Sleep Adv. 2025; 5(1):zpae094.

PMID: 39758351 PMC: 11697392. DOI: 10.1093/sleepadvances/zpae094.

Nurse-delivered brief behavioral treatment for insomnia in cancer survivors: a randomized controlled trial.

Dickerson S, Kwon M, Wilding G, Zhu J J Cancer Surviv. 2024; .

PMID: 39589721 DOI: 10.1007/s11764-024-01704-1.

Examining the barriers and recommendations for integrating more equitable insomnia treatment options in primary care.

Vargas I, Egeler M, Walker J, Benitez D Front Sleep. 2024; 2.

PMID: 39210962 PMC: 11361330. DOI: 10.3389/frsle.2023.1279903.

Effects of nurse-led brief behavioral treatment for insomnia in adults: a randomized controlled trial.

Chang K, Lin C, Jan Y, Gordon C, Lee H, Shih C J Clin Sleep Med. 2024; 20(11):1763-1772.

PMID: 38935053 PMC: 11530976. DOI: 10.5664/jcsm.11256.

References

Wang J, Wei Q, Wu X, Zhong Z, Li G . Brief behavioral treatment for patients with treatment-resistant insomnia. Neuropsychiatr Dis Treat. 2016; 12:1967-75. PMC: 4977084. DOI: 10.2147/NDT.S110571. View

Li Y, Zhang X, Winkelman J, Redline S, Hu F, Stampfer M . Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation. 2013; 129(7):737-46. PMC: 3987964. DOI: 10.1161/CIRCULATIONAHA.113.004500. View

Balduzzi S, Rucker G, Schwarzer G . How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019; 22(4):153-160. PMC: 10231495. DOI: 10.1136/ebmental-2019-300117. View

McCrae C, Curtis A, Williams J, Dautovich N, McNamara J, Stripling A . Efficacy of brief behavioral treatment for insomnia in older adults: examination of sleep, mood, and cognitive outcomes. Sleep Med. 2018; 51:153-166. PMC: 6513321. DOI: 10.1016/j.sleep.2018.05.018. View

Harris K, Schiele S, Emery C . Pilot randomized trial of brief behavioral treatment for insomnia in patients with heart failure. Heart Lung. 2019; 48(5):373-380. DOI: 10.1016/j.hrtlng.2019.06.003. View

Javaheri S, Redline S . Insomnia and Risk of Cardiovascular Disease. Chest. 2017; 152(2):435-444. PMC: 5577359. DOI: 10.1016/j.chest.2017.01.026. View

Morin C, Bootzin R, Buysse D, Edinger J, Espie C, Lichstein K . Psychological and behavioral treatment of insomnia:update of the recent evidence (1998-2004). Sleep. 2006; 29(11):1398-414. DOI: 10.1093/sleep/29.11.1398. View

Savard J, Laroche L, Simard S, Ivers H, Morin C . Chronic insomnia and immune functioning. Psychosom Med. 2003; 65(2):211-21. DOI: 10.1097/01.psy.0000033126.22740.f3. View

Watanabe N, Furukawa T, Shimodera S, Morokuma I, Katsuki F, Fujita H . Brief behavioral therapy for refractory insomnia in residual depression: an assessor-blind, randomized controlled trial. J Clin Psychiatry. 2011; 72(12):1651-8. DOI: 10.4088/JCP.10m06130gry. View

10.

Gunn H, Tutek J, Buysse D . Brief Behavioral Treatment of Insomnia. Sleep Med Clin. 2019; 14(2):235-243. DOI: 10.1016/j.jsmc.2019.02.003. View

11.

van Straten A, van der Zweerde T, Kleiboer A, Cuijpers P, Morin C, Lancee J . Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev. 2017; 38:3-16. DOI: 10.1016/j.smrv.2017.02.001. View

12.

Parthasarathy S, Vasquez M, Halonen M, Bootzin R, Quan S, Martinez F . Persistent insomnia is associated with mortality risk. Am J Med. 2014; 128(3):268-75.e2. PMC: 4340773. DOI: 10.1016/j.amjmed.2014.10.015. View

13.

Fuller J, Wong K, Hoyos C, Krass I, Saini B . Dispensing good sleep health behaviours not pills--a cluster-randomized controlled trial to test the feasibility and efficacy of pharmacist-provided brief behavioural treatment for insomnia. J Sleep Res. 2015; 25(1):104-15. DOI: 10.1111/jsr.12328. View

14.

Spira A, Kaufmann C, Kasper J, Ohayon M, Rebok G, Skidmore E . Association between insomnia symptoms and functional status in U.S. older adults. J Gerontol B Psychol Sci Soc Sci. 2014; 69 Suppl 1:S35-41. PMC: 4303065. DOI: 10.1093/geronb/gbu116. View

15.

Dean G, Weiss C, Jungquist C, Klimpt M, Alameri R, Ziegler P . Nurse-Delivered Brief Behavioral Treatment for Insomnia in Lung Cancer Survivors: A Pilot RCT. Behav Sleep Med. 2019; 18(6):774-786. PMC: 7190424. DOI: 10.1080/15402002.2019.1685523. View

16.

Hozo S, Djulbegovic B, Hozo I . Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005; 5:13. PMC: 1097734. DOI: 10.1186/1471-2288-5-13. View

17.

Buysse D, Germain A, Moul D, Franzen P, Brar L, Fletcher M . Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med. 2011; 171(10):887-95. PMC: 3101289. DOI: 10.1001/archinternmed.2010.535. View

18.

Atkin T, Comai S, Gobbi G . Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacol Rev. 2018; 70(2):197-245. DOI: 10.1124/pr.117.014381. View

19.

Troxel W, Germain A, Buysse D . Clinical management of insomnia with brief behavioral treatment (BBTI). Behav Sleep Med. 2012; 10(4):266-79. PMC: 3622949. DOI: 10.1080/15402002.2011.607200. View

20.

Germain A, Richardson R, Stocker R, Mammen O, Hall M, Bramoweth A . Treatment for insomnia in combat-exposed OEF/OIF/OND military veterans: preliminary randomized controlled trial. Behav Res Ther. 2014; 61:78-88. PMC: 4180045. DOI: 10.1016/j.brat.2014.07.016. View